Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Everolimus

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Everolimus

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 272,439Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche Reports Phase 3 Breast Cancer Victory for Oral Serd
    Roche Reports Phase 3 Breast Cancer Victory for Oral Serd

    24 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roche-reports-phase-3-breast-cancer-victory-starting-key-period-oral-serd-win

    FIERCE BIOTECH
    24 Sep 2025
    Share Share
    The company accomplished Ethyl Icosapentate, Everolimus audit
    The company accomplished Ethyl Icosapentate, Everolimus audit

    09 Sep 2025

    // PRESS RELEASE

    http://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=136

    PRESS RELEASE
    09 Sep 2025
    Share Share
    The company accomplished Everolimus audit
    The company accomplished Everolimus audit

    04 Sep 2025

    // PRESS RELEASE

    http://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=135

    PRESS RELEASE
    04 Sep 2025
    Share Share
    Breckenridge Gets FDA Nod For Everolimus Oral Suspension
    Breckenridge Gets FDA Nod For Everolimus Oral Suspension

    29 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/breckenridge-announces-final-fda-approval-for-everolimus-tablets-for-oral-suspension-ab-rated-to-afinitor-disperz-302363514.html

    PR NEWSWIRE
    29 Jan 2025
    Share Share
    Amneal Pharma`s Generics Everolimus Receives Approval in US
    Amneal Pharma`s Generics Everolimus Receives Approval in US

    10 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218863

    FDA
    10 Jan 2025
    Share Share
    Upsher-Smith Selects PANTHERx Rare For Distribution Of TORPENZ
    Upsher-Smith Selects PANTHERx Rare For Distribution Of TORPENZ

    20 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/upsher-smith-laboratories-llc-selects-pantherx-rare-for-the-distribution-of-torpenz-everolimus-tablets-302226487.html

    PR NEWSWIRE
    20 Aug 2024
    Share Share